Page last updated: 2024-08-17

adenosine diphosphate and hmr 1098

adenosine diphosphate has been researched along with hmr 1098 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, NW; Hudman, D; Norman, RI; Rainbow, RD; Standen, NB1
Akrouh, A; Kurata, HT; Lawton, JS; Nichols, CG; Remedi, MS; Zhang, HX1

Other Studies

2 other study(ies) available for adenosine diphosphate and hmr 1098

ArticleYear
Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
    Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:4

    Topics: Action Potentials; Adenosine Diphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Guanidines; Iodoacetates; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Pinacidil; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Rats; Rats, Wistar; Receptors, Drug; Sarcolemma; Sodium Cyanide; Sulfonylurea Compounds; Sulfonylurea Receptors

2005
HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
    Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Blood Glucose; Diazoxide; Insulin; Islets of Langerhans; KATP Channels; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pinacidil; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sarcolemma; Substrate Specificity; Sulfonylurea Receptors

2011